Join Arrowhead Pharmaceuticals for Part V of its 2024 Summer Series of R&D Webinars, featuring Jose Soria, MD (The Neuron Clinic). Arrowhead management will provide updates on its central nervous system (CNS) programs, including the development of its TRiM™ platform for intrathecal administration and a new structure designed for subcutaneous administration for delivery to the CNS. Arrowhead will also discuss the development of two new CNS candidates that are on schedule to start clinical development in 2024 and 2025.

A live question and answer session will follow the formal presentation.